Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Philipp KarnerAudio: American English

5 Longevity Breakthroughs That Just Happened This Week!

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

This week in longevity: a UC Berkeley paper in Aging-US shows a two-drug combo of oxytocin and an ALK5 inhibitor extended lifespan in old male mice by around 70% — but female mice only got short-term gains, raising big questions about sex-specific aging therapies. Plus: why naked mole-rats keep youthful skin at 40 years old (it's how their hyaluronic acid is organized, not how much they have), how Greenland sharks live 300 years with hearts that look damaged on every level (resilience to damage, not avoidance of it), a new npj Aging study from Hainan showing lifestyle outweighs longevity genes three to one in people over 90, and Abu Dhabi inviting the entire longevity industry to test technologies across its national health network — the first country-scale geroscience experiment. Five stories, three minutes. Follow for weekly longevity news that actually matters.

Philipp Karner · 3 min · Source published: 2026-05-16

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…